Literature DB >> 25851706

Sclerosing Stromal Tumors With Prominent Luteinization During Pregnancy: A Report of 8 Cases Emphasizing Diagnostic Problems.

Jennifer A Bennett1, Esther Oliva, Robert H Young.   

Abstract

Ovarian tumors encountered during pregnancy can pose a diagnostic challenge due to an abundance of luteinized cells and other changes. We report 8 sclerosing stromal tumors with massive luteinization discovered in pregnant patients. The tumors ranged from 3.1 to 21 cm (mean=8.8 cm) in size and were typically solid and yellow; the neoplasm was bilateral in 1 case. On microscopic examination, the lutein cells, a feature of sclerosing stromal tumor, had more copious eosinophilic cytoplasm and were more numerous than is usually seen in nonpregnant patients and to varying degrees obscured the typical pseudolobular pattern. This resulted in particular diagnostic difficulty in 3 cases, especially when associated with other changes including irregular shapes of tumor cell nests, edema, and/or myxoid change. However, classic features of these tumors: ectatic vessels and admixed luteinized and nonluteinized cells were still focally evident, allowing for accurate classification. The tumors were cytologically bland and with 1 exception had rare mitoses. As sclerosing stromal tumors have been invariably benign, it is important that they not be confused with other tumors, such as steroid cell tumor, which can occasionally be malignant.

Entities:  

Mesh:

Year:  2015        PMID: 25851706     DOI: 10.1097/PGP.0000000000000163

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  3 in total

1.  Different Presentations of Five Rare Cases of Sclerosing Stromal Tumor of the Ovary.

Authors:  Mozhdeh Momtahan; Mojgan Akbarzadeh-Jahromi; Fateme Sadat Najib; Niloofar Namazi
Journal:  Indian J Surg Oncol       Date:  2018-05-19

2.  Ultrasonographic and pathological features of sclerosing stromal tumor: a case report.

Authors:  Xuechen Qian; Xuhong Wang; Zhenbin Xu; Shengmin Zhang
Journal:  Gland Surg       Date:  2022-09

3.  Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary.

Authors:  Sarah H Kim; Arnaud Da Cruz Paula; Thais Basili; Higinio Dopeso; Rui Bi; Fresia Pareja; Edaise M da Silva; Rodrigo Gularte-Mérida; Zhen Sun; Sho Fujisawa; Caitlin G Smith; Lorenzo Ferrando; Ana Paula Martins Sebastião; Yonina Bykov; Anqi Li; Catarina Silveira; Charles W Ashley; Anthe Stylianou; Pier Selenica; Wesley R Samore; Achim A Jungbluth; Dmitriy Zamarin; Nadeem R Abu-Rustum; Kristian Helin; Robert A Soslow; Jorge S Reis-Filho; Esther Oliva; Britta Weigelt
Journal:  Nat Commun       Date:  2020-01-02       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.